What about the mental health of clinical trial participants?
“Why is my disease less important than COVID?” Donna asked me toward the end of our phone call.
Two years ago, after celebrating her 65th birthday, she was diagnosed with acute myeloid leukemia—an aggressive type of blood cancer—which turned out to be refractory to conventional chemotherapy. After spending hundreds of hours with doctors and social workers, she was scheduled to enroll in a clinical trial in May 2020. But COVID-19 postponed it.
She is …